Cargando…
Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach
Assessment of distal cerebral perfusion after ischaemic stroke is currently only possible through expensive and time-consuming imaging procedures which require the injection of a contrast medium. Alternative approaches that could indicate earlier the impact of blood flow occlusion on distal cerebral...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079032/ https://www.ncbi.nlm.nih.gov/pubmed/35364704 http://dx.doi.org/10.1007/s10439-022-02956-7 |
_version_ | 1784702471633895424 |
---|---|
author | Benemerito, Ivan Narata, Ana Paula Narracott, Andrew Marzo, Alberto |
author_facet | Benemerito, Ivan Narata, Ana Paula Narracott, Andrew Marzo, Alberto |
author_sort | Benemerito, Ivan |
collection | PubMed |
description | Assessment of distal cerebral perfusion after ischaemic stroke is currently only possible through expensive and time-consuming imaging procedures which require the injection of a contrast medium. Alternative approaches that could indicate earlier the impact of blood flow occlusion on distal cerebral perfusion are currently lacking. The aim of this study was to identify novel biomarkers suitable for clinical implementation using less invasive diagnostic techniques such as Transcranial Doppler (TCD). We used 1D modelling to simulate pre- and post-stroke velocity and flow wave propagation in a typical arterial network, and Sobol’s sensitivity analysis, supported by the use of Gaussian process emulators, to identify biomarkers linked to cerebral perfusion. We showed that values of pulsatility index of the right anterior cerebral artery > 1.6 are associated with poor perfusion and may require immediate intervention. Three additional biomarkers with similar behaviour, all related to pulsatility indices, were identified. These results suggest that flow pulsatility measured at specific locations could be used to effectively estimate distal cerebral perfusion rates, and ultimately improve clinical diagnosis and management of ischaemic stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10439-022-02956-7. |
format | Online Article Text |
id | pubmed-9079032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-90790322022-05-09 Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach Benemerito, Ivan Narata, Ana Paula Narracott, Andrew Marzo, Alberto Ann Biomed Eng Original Article Assessment of distal cerebral perfusion after ischaemic stroke is currently only possible through expensive and time-consuming imaging procedures which require the injection of a contrast medium. Alternative approaches that could indicate earlier the impact of blood flow occlusion on distal cerebral perfusion are currently lacking. The aim of this study was to identify novel biomarkers suitable for clinical implementation using less invasive diagnostic techniques such as Transcranial Doppler (TCD). We used 1D modelling to simulate pre- and post-stroke velocity and flow wave propagation in a typical arterial network, and Sobol’s sensitivity analysis, supported by the use of Gaussian process emulators, to identify biomarkers linked to cerebral perfusion. We showed that values of pulsatility index of the right anterior cerebral artery > 1.6 are associated with poor perfusion and may require immediate intervention. Three additional biomarkers with similar behaviour, all related to pulsatility indices, were identified. These results suggest that flow pulsatility measured at specific locations could be used to effectively estimate distal cerebral perfusion rates, and ultimately improve clinical diagnosis and management of ischaemic stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10439-022-02956-7. Springer International Publishing 2022-04-01 2022 /pmc/articles/PMC9079032/ /pubmed/35364704 http://dx.doi.org/10.1007/s10439-022-02956-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Benemerito, Ivan Narata, Ana Paula Narracott, Andrew Marzo, Alberto Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach |
title | Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach |
title_full | Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach |
title_fullStr | Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach |
title_full_unstemmed | Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach |
title_short | Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach |
title_sort | determining clinically-viable biomarkers for ischaemic stroke through a mechanistic and machine learning approach |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079032/ https://www.ncbi.nlm.nih.gov/pubmed/35364704 http://dx.doi.org/10.1007/s10439-022-02956-7 |
work_keys_str_mv | AT benemeritoivan determiningclinicallyviablebiomarkersforischaemicstrokethroughamechanisticandmachinelearningapproach AT narataanapaula determiningclinicallyviablebiomarkersforischaemicstrokethroughamechanisticandmachinelearningapproach AT narracottandrew determiningclinicallyviablebiomarkersforischaemicstrokethroughamechanisticandmachinelearningapproach AT marzoalberto determiningclinicallyviablebiomarkersforischaemicstrokethroughamechanisticandmachinelearningapproach |